The potential role of environmentally associated DNA methylation in childhood acute lymphoblastic leukaemia subtypes
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35506 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Jessica R Saville und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Life Sciences, Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: DNA Methylation, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Environmental Exposure. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, World Cancer Research Fund, CHILDREN with CANCER UK.
Abstract (Originalsprache)
Various genetic aberrations are suggested to initiate the development of acute lymphoblastic leukaemia (ALL) but alone are insufficient for disease onset. Epigenetic alteration, such as DNA methylation changes, plays a key role in human health. Evidence suggests DNA methylation may be an intermediate mechanism through which the environment contributes to ALL manifestation. ALL is categorized into subtypes based on leukaemia‐associated genetic events, and it is plausible that different exposures pose differing risks for given subtypes. Using our previously established meet‐in‐the‐middle approach, we performed CpG‐level analysis to investigate DNA methylation as an intermediate mechanism between risk exposures and ALL. Differentially methylated CpGs (DMCs) were integrated, identifying overlapping methylation, with hypergeometric tests used to assess the probability of concurring methylation considering directionality. DMC analysis reinforced previous gene‐level findings suggesting altered DNA methylation associated with maternal radiation exposure, alcohol intake, and plasma folate during pregnancy is also present in the disease. Whilst maternal folate‐associated and leukaemia‐associated methylation appear consistent across most subtypes, the effect of other exposures appears subtype‐specific. We suggest environmentally associated methylation includes driver and/or ‘navigator’ changes, the latter influencing biological pathways contributing to ALL. This analysis aids understanding of which risk factors may contribute to specific subtypes or which influence ALL risk more generally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health and Life Sciences, Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK.
- Biosciences Institute, Newcastle University Centre for Cancer, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK.
- St. George's University, Grenada, Based at Northumbria University, Newcastle upon Tyne, UK.
- Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.
- Department of Medical Sciences, Molecular Precision Medicine, Science For Life Laboratory, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Jessica R Saville
Förderung
- World Health Organization
- World Cancer Research Fund
- CHILDREN with CANCER UK
- Northumbria University
Zitieren
APA
Saville, J. R., Russell, L. J., Padget, K., Ghantous, A., Nordlund, J., & McKay, J. A. (2025). The potential role of environmentally associated DNA methylation in childhood acute lymphoblastic leukaemia subtypes. International Journal of Cancer. https://doi.org/10.1002/ijc.35506
Vancouver
Saville JR, Russell LJ, Padget K, Ghantous A, Nordlund J, McKay JA. The potential role of environmentally associated DNA methylation in childhood acute lymphoblastic leukaemia subtypes. International Journal of Cancer. 2025. doi:10.1002/ijc.35506
BibTeX
@article{Saville2025,
author = {Saville, Jessica R and Russell, Lisa J and Padget, Kay and Ghantous, Akram and Nordlund, Jessica and McKay, Jill A},
title = {The potential role of environmentally associated DNA methylation in childhood acute lymphoblastic leukaemia subtypes},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35506}
}
EUVIMED